BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24636797)

  • 1. APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome.
    Trazzi S; Fuchs C; De Franceschi M; Mitrugno VM; Bartesaghi R; Ciani E
    Neurobiol Dis; 2014 Jul; 67():24-36. PubMed ID: 24636797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amyloid precursor protein (APP) triplicated gene impairs neuronal precursor differentiation and neurite development through two different domains in the Ts65Dn mouse model for Down syndrome.
    Trazzi S; Fuchs C; Valli E; Perini G; Bartesaghi R; Ciani E
    J Biol Chem; 2013 Jul; 288(29):20817-20829. PubMed ID: 23740250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome.
    Trazzi S; Mitrugno VM; Valli E; Fuchs C; Rizzi S; Guidi S; Perini G; Bartesaghi R; Ciani E
    Hum Mol Genet; 2011 Apr; 20(8):1560-73. PubMed ID: 21266456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice.
    Stagni F; Giacomini A; Guidi S; Ciani E; Ragazzi E; Filonzi M; De Iasio R; Rimondini R; Bartesaghi R
    Neurobiol Dis; 2015 Feb; 74():204-18. PubMed ID: 25497735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome.
    Giacomini A; Stagni F; Trazzi S; Guidi S; Emili M; Brigham E; Ciani E; Bartesaghi R
    Neurobiol Dis; 2015 Oct; 82():385-396. PubMed ID: 26254735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome.
    Bianchi P; Ciani E; Guidi S; Trazzi S; Felice D; Grossi G; Fernandez M; Giuliani A; Calzà L; Bartesaghi R
    J Neurosci; 2010 Jun; 30(26):8769-79. PubMed ID: 20592198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.
    Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R
    Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome.
    Stagni F; Salvalai ME; Giacomini A; Emili M; Uguagliati B; Xia E; Grilli M; Bartesaghi R; Guidi S
    Neurobiol Dis; 2019 Sep; 129():44-55. PubMed ID: 31085229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome.
    Stagni F; Raspanti A; Giacomini A; Guidi S; Emili M; Ciani E; Giuliani A; Bighinati A; Calzà L; Magistretti J; Bartesaghi R
    Neurobiol Dis; 2017 Jul; 103():11-23. PubMed ID: 28359846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurogenesis impairment: An early developmental defect in Down syndrome.
    Stagni F; Giacomini A; Emili M; Guidi S; Bartesaghi R
    Free Radic Biol Med; 2018 Jan; 114():15-32. PubMed ID: 28756311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice.
    Mazur-Kolecka B; Golabek A; Kida E; Rabe A; Hwang YW; Adayev T; Wegiel J; Flory M; Kaczmarski W; Marchi E; Frackowiak J
    J Neurosci Res; 2012 May; 90(5):999-1010. PubMed ID: 22252917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome.
    Shukkur EA; Shimohata A; Akagi T; Yu W; Yamaguchi M; Murayama M; Chui D; Takeuchi T; Amano K; Subramhanya KH; Hashikawa T; Sago H; Epstein CJ; Takashima A; Yamakawa K
    Hum Mol Genet; 2006 Sep; 15(18):2752-62. PubMed ID: 16891409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS.
    Stagni F; Giacomini A; Guidi S; Emili M; Uguagliati B; Salvalai ME; Bortolotto V; Grilli M; Rimondini R; Bartesaghi R
    Exp Neurol; 2017 Dec; 298(Pt A):79-96. PubMed ID: 28882412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium Restores Age-related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome.
    Guidi S; Bianchi P; Stagni F; Giacomini A; Emili M; Trazzi S; Ciani E; Bartesaghi R
    CNS Neurol Disord Drug Targets; 2017; 16(7):812-819. PubMed ID: 27488422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorder.
    Fuchs C; Rimondini R; Viggiano R; Trazzi S; De Franceschi M; Bartesaghi R; Ciani E
    Neurobiol Dis; 2015 Oct; 82():298-310. PubMed ID: 26143616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal and brain region-specific elevations of soluble Amyloid-β
    Tallino S; Winslow W; Bartholomew SK; Velazquez R
    Aging Cell; 2022 Apr; 21(4):e13590. PubMed ID: 35290711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome.
    Giacomini A; Stagni F; Emili M; Guidi S; Salvalai ME; Grilli M; Vidal-Sanchez V; Martinez-Cué C; Bartesaghi R
    Brain Res Bull; 2018 Jun; 140():378-391. PubMed ID: 29935232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progranulin enhances neural progenitor cell proliferation through glycogen synthase kinase 3β phosphorylation.
    Nedachi T; Kawai T; Matsuwaki T; Yamanouchi K; Nishihara M
    Neuroscience; 2011 Jun; 185():106-15. PubMed ID: 21540081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subicular hypotrophy in fetuses with Down syndrome and in the Ts65Dn model of Down syndrome.
    Stagni F; Giacomini A; Emili M; Uguagliati B; Bonasoni MP; Bartesaghi R; Guidi S
    Brain Pathol; 2019 May; 29(3):366-379. PubMed ID: 30325080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.